ArticleOncoimmunology2013

Co-stimulatory tumor necrosis factor ligands as adjuvants for the development of subunit-based anticancer vaccines.

Haval Shirwan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.